These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Von Willebrand factor and platelet adhesion to the subendothelium of the vascular wall]. Meyer D Nouv Rev Fr Hematol (1978); 1982; 24(3):145-51. PubMed ID: 6752879 [TBL] [Abstract][Full Text] [Related]
23. Targeting of liposomes carrying recombinant fragments of platelet membrane glycoprotein Ibalpha to immobilized von Willebrand factor under flow conditions. Nishiya T; Murata M; Handa M; Ikeda Y Biochem Biophys Res Commun; 2000 Apr; 270(3):755-60. PubMed ID: 10772897 [TBL] [Abstract][Full Text] [Related]
24. Platelets selectively enhance lymphocyte adhesion on subendothelial matrix under arterial flow conditions. Spectre G; Zhu L; Ersoy M; Hjemdahl P; Savion N; Varon D; Li N Thromb Haemost; 2012 Aug; 108(2):328-37. PubMed ID: 22688347 [TBL] [Abstract][Full Text] [Related]
25. The Flow Dependent Adhesion of von Willebrand Factor (VWF)-A1 Functionalized Nanoparticles in an in Vitro Coronary Stenosis Model. Asaad Y; Epshtein M; Yee A; Korin N Molecules; 2019 Jul; 24(15):. PubMed ID: 31344782 [TBL] [Abstract][Full Text] [Related]
26. Reduced high shear platelet adhesion to the vascular media: defective von Willebrand factor binding to the interstitial collagen. Komorowic E; McBane RD; Charlesworth J; Fass DN Thromb Haemost; 2002 Apr; 87(4):763-70. PubMed ID: 12013023 [TBL] [Abstract][Full Text] [Related]
27. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin. Olson JD; Zaleski A; Herrmann D; Flood PA J Lab Clin Med; 1989 Jul; 114(1):6-18. PubMed ID: 2786916 [TBL] [Abstract][Full Text] [Related]
28. Recombinant vWF type 2A mutants R834Q and R834W show a defect in mediating platelet adhesion to collagen, independent of enhanced sensitivity to a plasma protease. Lankhof H; Damas C; Schiphorst ME; Ijsseldijk MJ; Bracke M; Furlan M; de Groot PG; Sixma JJ; Vink T Thromb Haemost; 1999 Jun; 81(6):976-83. PubMed ID: 10404778 [TBL] [Abstract][Full Text] [Related]
29. Glycoprotein Ib has a partial role in platelet-von Willebrand factor collagen interaction. Aihara M; Tamura K; Kawarada R; Okawa K; Yoshida Y Thromb Haemost; 1988 Oct; 60(2):182-7. PubMed ID: 3064358 [TBL] [Abstract][Full Text] [Related]
30. A revised model of platelet aggregation. Kulkarni S; Dopheide SM; Yap CL; Ravanat C; Freund M; Mangin P; Heel KA; Street A; Harper IS; Lanza F; Jackson SP J Clin Invest; 2000 Mar; 105(6):783-91. PubMed ID: 10727447 [TBL] [Abstract][Full Text] [Related]
31. von Willebrand factor without the A2 domain is resistant to proteolysis. Lankhof H; Damas C; Schiphorst ME; Ijsseldijk MJ; Bracke M; Furlan M; Tsai HM; de Groot PG; Sixma JJ; Vink T Thromb Haemost; 1997 May; 77(5):1008-13. PubMed ID: 9184419 [TBL] [Abstract][Full Text] [Related]
32. The role of von Willebrand factor in platelet function. de Groot PG Semin Thromb Hemost; 2002 Apr; 28(2):133-8. PubMed ID: 11992236 [TBL] [Abstract][Full Text] [Related]
33. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib. Girma JP; Fressinaud E; Christophe O; Rouault C; Obert B; Takahashi Y; Meyer D Thromb Haemost; 1992 Dec; 68(6):707-13. PubMed ID: 1287886 [TBL] [Abstract][Full Text] [Related]
34. In vitro characterization of SynthoPlate™ (synthetic platelet) technology and its in vivo evaluation in severely thrombocytopenic mice. Shukla M; Sekhon UD; Betapudi V; Li W; Hickman DA; Pawlowski CL; Dyer MR; Neal MD; McCrae KR; Sen Gupta A J Thromb Haemost; 2017 Feb; 15(2):375-387. PubMed ID: 27925685 [TBL] [Abstract][Full Text] [Related]
35. Influence of Brownian motion on blood platelet flow behavior and adhesive dynamics near a planar wall. Mody NA; King MR Langmuir; 2007 May; 23(11):6321-8. PubMed ID: 17417890 [TBL] [Abstract][Full Text] [Related]
36. Platelet interactions with liposomes carrying recombinant platelet membrane glycoproteins or fibrinogen: approach to platelet substitutes. Nishiya T; Kainoh M; Murata M; Handa M; Ikeda Y Artif Cells Blood Substit Immobil Biotechnol; 2001 Nov; 29(6):453-64. PubMed ID: 11795631 [TBL] [Abstract][Full Text] [Related]
37. Heteromultivalent liposomal nanoconstructs for enhanced targeting and shear-stable binding to active platelets for site-selective vascular drug delivery. Modery CL; Ravikumar M; Wong TL; Dzuricky MJ; Durongkaveroj N; Sen Gupta A Biomaterials; 2011 Dec; 32(35):9504-14. PubMed ID: 21906806 [TBL] [Abstract][Full Text] [Related]
38. Interaction of platelets with liposomes containing dodecapeptide sequence from fibrinogen. Nishiya T; Toma C Thromb Haemost; 2004 Jun; 91(6):1158-67. PubMed ID: 15175803 [TBL] [Abstract][Full Text] [Related]
39. Relipidated tissue factor linked to collagen surfaces potentiates platelet adhesion and fibrin formation in a microfluidic model of vessel injury. Colace TV; Jobson J; Diamond SL Bioconjug Chem; 2011 Oct; 22(10):2104-9. PubMed ID: 21902184 [TBL] [Abstract][Full Text] [Related]
40. Multimerin 1 supports platelet function in vivo and binds to specific GPAGPOGPX motifs in fibrillar collagens that enhance platelet adhesion. Leatherdale A; Parker D; Tasneem S; Wang Y; Bihan D; Bonna A; Hamaia SW; Gross PL; Ni H; Doble BW; Lillicrap D; Farndale RW; Hayward CPM J Thromb Haemost; 2021 Feb; 19(2):547-561. PubMed ID: 33179420 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]